GGrantIndex
Sort

172,184 grants matching inflammation

Novel Therapeutic Targets for Venous Thromboembolism

$724,184
Thomas William Wakefield · University Of Michigan At Ann Arbor · R01 · FY2011 · HL

Injectable Biomaterial for Treating Hypoplastic Left Heart Syndrome

$724,183
Michael E Davis · Emory University · R01 · FY2022 · HL

Facilitating islet implantation and engraftment following transplantation using primed umbilical cord mesenchymal stem therapies and focused ultrasound

$724,180
Avnesh Sinh Thakor · Stanford University · R01 · FY2025 · DK

Gut barrier function in Alzheimer’s disease

$724,177
Barbara Brigitta Bendlin · University Of Wisconsin-Madison · R01 · FY2025 · AG

The Effects of a Standardized Research E-Cigarette On The Human Lung: A Clinical Trial With Bronchoscopic Biomarkers

$724,169
Peter G. Shields · Ohio State University · U01 · FY2018 · DA

Determinants of insufficient sleep among blacks and effects on disparities in health outcomes

$724,168
Girardin Jean-Louis · University Of Miami School Of Medicine · R01 · FY2022 · HL

Identifying adolescents at high risk of neurocognitive disorder: Development and validation of a composite risk index

$724,145
Amara E Ezeamama · Michigan State University · R01 · FY2020 · NS

Genetic architecture of host response to tickborne disease in Peromyscus leucopus

$724,038
Anthony Douglas Long · University Of California-Irvine · R01 · FY2020 · AI

The impact of brain lipoprotein structure and composition on amyloid beta metabolism and Alzheimer's disease

$724,016
John Melchior · Battelle Pacific Northwest Laboratories · R01 · FY2025 · NS

Cellular mediators of vascular inflammation in treated HIV-infection

$724,015
Nicholas T. Funderburg · Ohio State University · R01 · FY2019 · HL

Redox Mechanism Process of Angiogenesis and Wound Healing

$723,973
David Wink · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Impact of inflammatory lipids on Yersinia pestis infection

$723,955
Matthew Lawrenz · University Of Louisville · R01 · FY2024 · AI

Impact of inflammatory lipids on Yersinia pestis infection

$723,955
Matthew Lawrenz · University Of Louisville · R01 · FY2025 · AI

Rheumatoid Arthritis-Related Autoantibodies, Articular Inflammation, and RA-Associated Interstitial Lung Disease

$723,953
Jeffrey Andrew Sparks · Brigham And Women'S Hospital · R01 · FY2022 · AR

Technical Validation of MR Biomarkers of Obesity-Associated NAFLD

$723,934
Scott B. Reeder · University Of Wisconsin-Madison · R01 · FY2021 · DK

Fish Oil for Atrial Fibrillation-Effect and Mechanisms

$723,919
Charles M. Stein · Vanderbilt University · R01 · FY2011 · HL

Depression and Heart Failure Disease Progression

$723,872
Andrew Sherwood · Duke University · R01 · FY2015 · HL

Black carbon exposure, DNA methylation, airway inflammation in pediatric asthma

$723,858
Rachel L Miller · Columbia University Health Sciences · R01 · FY2014 · ES

Systematic identification of minor histocompatibility antigens to address GVHD

$723,738
Derin B Keskin · Dana-Farber Cancer Inst · R01 · FY2024 · HL

The longer-term impact of prenatal exposure to SARS-CoV-2 infection and the COVID-19 vaccine on behavior, cognition, and brain functioning in the child

$723,710
Anna-Sophie Rommel · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · HD

High Efficiency Delivery of Surfactant Aerosols to Infants without Intubation

$723,687
P. Worth Longest · Virginia Commonwealth University · R01 · FY2020 · HL

Long-term effects of electronic cigarettes on brain health

$723,676
Merideth A. Addicott · Wake Forest University Health Sciences · R01 · FY2025 · DA

Brain-based and clinical phenotyping of pain pharmacotherapy in knee OA

$723,674
Thomas Jack Schnitzer · Northwestern University At Chicago · R01 · FY2023 · AR

Synthetic Multivalent Galectin Assemblies as Anti-Inflammatory Therapies

$723,656
Gregory Hudalla · University Of Florida · R01 · FY2024 · AI

Body composition and adiposity-associated thromboinflammation in colorectal cancer prognosis

$723,643
Doratha Armenthus Byrd · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA